Genetic basis of Blood Cancer (Chronic Myeloid Leukemia: CML) and Its Treatment
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the one marrow and the accumulation of these cells in the blood. CML is a clonal bone marrow stem cell disorder in which a proliferation of mature granulocytes and their precursors is found. It is a type of myeloproliferative neoplasm associated with a characteristic chromosomal translocation called the Philadelphia chromosome.
CML is largely treated with targeted drugs called tyrosine-kinase inhibitors (TKIs) which have led to dramatically improved long-term survival rates since 2001.
If you have any questions then you can comment or can DM us in Instagram....
https://www.instagram.com/ssbio_log
Do follow us on our facebook page
https://www.facebook.com/ssbiolog23/
Our eamil : ssbiologg@gmail.com
-
Category
No comments found